Achievements
- Founded SFA Therapeutics, a Y Combinator-backed biotech startup focused on microbiome-derived drugs for chronic inflammatory diseases and cancer
- Led transformation of American Home Products into Wyeth and served as global VP at Pfizer after acquisition
- Accumulated extensive leadership experience at Wyeth/Pfizer, Allergan, ICON plc, PA Consulting, Mars Electronics, and Air Products & Chemicals
- Inspired to start SFA after early promising liver cancer research at Temple University in 2015
- SFA Therapeutics aims to develop functional cures by targeting root causes of autoimmune and inflammatory diseases
- Early human results for SFA's treatments show promise in addressing underlying disease mechanisms
Check out Ira Spector
Yo, peep this story about Ira Spector. This guy’s the real deal in biotech, no cap. He’s the CEO and co-founder of SFA Therapeutics, a Y Combinator-backed startup that’s actually trying to change the game in treating chronic inflammatory diseases and cancer. Like, they’re not just throwing pills at symptoms, they’re aiming for functional cures, which is pretty wild.
So, Ira’s got a crazy background in pharma. He’s been around the block with some heavy hitters, helped transform American Home Products into Wyeth, then rolled with Pfizer after they bought Wyeth in 2010. He was a global VP there, so the dude knows how to scale and operate in big pharma worlds. Before all that, he also worked at Allergan, ICON PLC, PA Consulting, Mars Electronics, and Air Products & Chemicals. Basically, he’s seen the pharma and tech worlds from every angle.
What really lights him up, though, is the science side. Back in 2015, he hears about some promising liver cancer research at Temple University. That moment sparked him to jump into biotech, co-found SFA Therapeutics. And get this, early human results were actually promising, so he’s all in now, pushing hard to turn these microbiome-derived drugs into something that can actually heal people, not just manage their symptoms.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herWhat does this say about him? Man, Ira’s driven by a real desire to make a difference. He’s not just in it for the money or fame, he genuinely wants to solve big health problems. His background in big pharma shows he knows how to scale and develop drugs, but his move into biotech and working on these new treatments proves he’s got the guts to chase real innovation.
Starting SFA wasn’t just a business move; it was a mission. It’s like he saw the bullshit in just treating symptoms and decided, “Nope, we’re gonna attack the root cause.” That’s a different kind of motivation, one that’s about impact, not just profits. He’s all about pushing the boundaries of what’s possible in medicine, and his process from corporate giant to startup founder shows he’s not afraid to jump into the deep end if it means making real change.
So yeah, Ira Spector is that rare mix of hardcore pharma vet and relentless innovator. He’s not just building a startup, he’s out here trying to rewrite the rules of medicine, and honestly, that’s pretty inspiring.

Select your comment type:
If something is wrong about Ira Spector, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)